ALBO

Albireo Pharma, Inc. Common Stock
ALBO

Overview Fund Activity
Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

22 hedge funds and large institutions have $54.4M invested in Albireo Pharma, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 6 closing their positions.

Holders
22
Holders Change
-2
Holders Change %
-8.33%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
5
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$3.91M
2
Deutsche Bank
2
Deutsche Bank
Germany
$1.43M
3
Geode Capital Management
3
Geode Capital Management
Massachusetts
$667K
4
SFM
4
Sphera Funds Management
Israel
$2.27M
5
BlackRock
5
BlackRock
New York
$229K

Top Sellers

1
SAM
1
Sectoral Asset Management
Quebec, Canada
$3.31M
2
Alyeska Investment Group
2
Alyeska Investment Group
Illinois
$0
3
Renaissance Technologies
3
Renaissance Technologies
New York
$2.84M
4
Northern Trust
4
Northern Trust
Illinois
$0
5
PVH
5
Psagot Value Holdings
Israel
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Creative Planning
26
Creative Planning
Kansas
– – -5 Closed
UBS Group
27
UBS Group
Switzerland
– – -1 Closed
Group One Trading
28
Group One Trading
Illinois
$0 2 – –
1
2